1. Epithelial-to-Mesenchymal Transition and Cancer Invasiveness: What Can We Learn from Cholangiocarcinoma?
   Simone Brivio et al, 2015, JCM CrossRef
2. Epithelial-mesenchymal transition in cholangiocarcinoma: From clinical evidence to regulatory networks.
   Javier Vaquero et al, 2017, J Hepatol CrossRef
3. Diverse gene expression patterns in response to anticancer drugs between human and mouse cell lines revealed by a comparative transcriptomic analysis
   Yong Guo et al, 2017 CrossRef
4. Adrenomedullin mediates pro-angiogenic and pro-inflammatory cytokines in asthma and COPD
   Jyotshna Mandal et al, 2019, Pulmonary Pharmacology & Therapeutics CrossRef
5. Insulin resistance in obese adolescents and adult men modifies the expression of proliferation related genes
   O. H. Minchenko et al, 2019, Ukr.Biochem.J CrossRef
6. MiR-590-3p suppresses epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma by inhibiting SIP1 expression
   Chao Zu et al, 2017, Oncotarget CrossRef
7. Screening effective differential expression genes for hepatic carcinoma with metastasis in the peripheral blood mononuclear cells by RNA-seq
   Yanting Shen et al, 2017, Oncotarget CrossRef
8. Molecular Mechanisms Driving Cholangiocarcinoma Invasiveness: An Overview
   Simone Brivio et al, 2018, gene expr CrossRef
9. Gel-forming antagonist provides a lasting effect on CGRP-induced vasodilation
   Chia Lin Chang et al, 2022, Front. Pharmacol. CrossRef
10. Peptidergic Systems and Cancer: Focus on Tachykinin and Calcitonin/Calcitonin Gene-Related Peptide Families
    Manuel Lisardo Sánchez et al, 2023, Cancers CrossRef
11. Aspartate β-hydroxylase (ASPH) Accelerates Intrahepatic Cholangiocarcinoma Metastasis via Upregulating SHH Signaling Pathway
    Yiran Zou et al, 2023, CPPS CrossRef